Online Trial Tracker - Larvol Sigma

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

cyclosporine / Generic mfg.

NCT00281879: Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

Terminated

200

anti-thymocyte globulin, ATG, filgrastim, G-CSF, busulfan, carmustine, cyclophosphamide, cyclosporine, cytarabine, etoposide, fludarabine phosphate, melphalan, methotrexate, methylprednisolone, mycophenolate mofetil, tacrolimus, FK-506, peripheral blood stem cell transplantation, umbilical cord blood transplantation, radiation therapy

OHSU Knight Cancer Institute, National Cancer Institute (NCI)

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unusual Cancers of Childhood

02/08

03/08

NCT00719849: Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease

Terminated

anti-thymocyte globulin, cyclophosphamide, cyclosporine, fludarabine phosphate, mycophenolate mofetil, umbilical cord blood transplantation, total body irradiation

Fred Hutchinson Cancer Center, National Cancer Institute (NCI)

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases

11/08

12/09

NCT00609739: Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation

Terminated

1/2

cyclosporine, CSA, cytarabine, Ara-C, filgrastim, G-CSF, methotrexate, MTX, methylprednisolone, Medrol, mitoxantrone hydrochloride, Mitoxantrone, allogeneic bone marrow transplantation, umbilical cord blood transplantation, Cis-Retinoic acid, isotretinoin

Masonic Cancer Center, University of Minnesota

Leukemia

06/10



	Diseases Companies Products Productz Mechanisms of Action Sites